PENTABIO

This brand name is authorized in Nigeria.

Active ingredients

The drug PENTABIO contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
 
Read more about Diphtheria toxoid
2
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
 
Read more about Tetanus toxoid
3
 
Read more about Pertussis toxoid
4
 

Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer.

 
Read more about Hepatitis B, purified antigen
5
UNII F2TW0N64FI - HAEMOPHILUS INFLUENZAE TYPE B
 

Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.

 
Read more about Haemophilus influenzae B

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A6-100062, A6-100069
Switch country to Nigeria in order to find specific presentations of PENTABIO

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈